Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure

被引：19

作者：

Ostronoff, Fabiana ^{[1
]}

Ostronoff, Mauricio ^{[1
]}

Calixto, Rodolfo ^{[1
]}

Florencio, Rodrigo ^{[1
]}

Domingues, Mariana C. ^{[1
]}

Souto Maior, Ana Patricia ^{[1
]}

Sucupira, Alexandre ^{[1
]}

Tagliari, Clemente ^{[1
]}

机构：

[1] Real Hosp Portugues, Hematol & Bone Marrow Transplantat Unit, Recife, PE, Brazil

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 03期

关键词：

D O I：

10.1016/j.bbmt.2006.11.015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：366 / 368

页数：3

共 23 条

[1]

AYAS M, 2005, PEDIAT BLOOD CANC

[2] Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects [J].

Bacigalupo, A .

BONE MARROW TRANSPLANTATION, 2005, 35 (03) :225-231

[3] Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia:: a report from the EBMT-SAA Working Party [J].

Bacigalupo, A ;

Locatelli, F ;

Lanino, E ;

Marsh, J ;

Socié, G ;

Maury, S ;

Prete, A ;

Locasciulli, A ;

Cesaro, S ;

Passweg, J .

BONE MARROW TRANSPLANTATION, 2005, 36 (11) :947-950

[4] Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) [J].

Bacigalupo, A ;

Lamparelli, T ;

Bruzzi, P ;

Guidi, S ;

Alessandrino, PE ;

di Bartolomeo, P ;

Oneto, R ;

Bruno, B ;

Barbanti, M ;

Sacchi, N ;

Van Lint, MT ;

Bosi, A .

BLOOD, 2001, 98 (10) :2942-2947

[5]

Bagby Grover C, 2004, Hematology Am Soc Hematol Educ Program, P318

[6] LATE VASCULAR COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION FOR DYSKERATOSIS-CONGENITA [J].

BERTHOU, C ;

DEVERGIE, A ;

DAGAY, MF ;

SONSINO, E ;

SCROBOHACI, ML ;

LOIRAT, C ;

GLUCKMAN, E .

BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (02) :335-344

[7] Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen [J].

Brazzola, P ;

Duval, M ;

Fournet, JC ;

Gauvin, F ;

Dalle, JH ;

Champagne, J ;

Champagne, MA .

BONE MARROW TRANSPLANTATION, 2005, 36 (12) :1103-1105

[8]

CONTER V, 1988, AM J PEDIAT HEMATOL, V10, P99

[9] Dyskeratosis congenita in all its forms [J].

Dokal, I .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (04) :768-779

[10] Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita [J].

Dror, Y ;

Freedman, MH ;

Leaker, M ;

Verbeek, J ;

Armstrong, CA ;

Saunders, FE ;

Doyle, JJ .

BONE MARROW TRANSPLANTATION, 2003, 31 (10) :847-850

← 1 2 3 →